Syphilis Testing Market Statistics, 2030
The global syphilis testing market size was valued at $1.1 billion in 2020, and is projected to reach $1.9 billion by 2030, growing at a CAGR of 5.6% from 2021 to 2030. Syphilis is a sexually transmitted infection caused by bacteria, Treponema pallidium. It is most infectious in the first two stages. The first stage of syphilis is in the hidden, or latent, stage, at which it will not harm the patient. The disease remains active but there are no symptoms. The second stage is called as tertiary syphilis, which is most destructive to health.
The primary stage of syphilis occurs about three to four weeks after a person contracts the bacteria. The symptoms after primary infection include, one or more open sores called chancres, which often feel firm and painless & swollen lymph nodes. The symptoms after secondary infection include, neck stiffness, headaches, hearing loss, problems with your reflexes, and paralysis. The untreated syphilis moves to the tertiary stage causing the re-occurrence of lesions and more severe symptoms, such as serious multi-organ infections, and vascular and neurological damage. Congenital syphilis occurs when a syphilis-infected mother passes the infection onto her baby during pregnancy, which can lead to stillbirth or death shortly after birth, miscarriage, prematurity, deformed bones, and brain and nerve problems of the baby. There are different tests used for identification of syphilis infection, such as Rapid plasma reagin (RPR), a syphilis blood test that looks for antibodies against the syphilis bacteria. Antibodies are proteins made by the immune system to fight foreign substances, such as bacteria. Venereal disease research laboratory (VDRL) test also checks for syphilis antibodies.
The key factor that drives the syphilis testing market growth is rise in incidence rate and increase in prevalence rate of syphilis. There are increasing incidences / new infections that are transmitted by and among MSM (Men who have sex with men) population, injecting drug users, and sex workers. Also, many syphilis remain asymptomatic during infectious phase and hence, are often undetectably transmitted.
Another key factors, such as implementation of screening program and increase in awareness about sex, lead to syphilis testing market growth. Hence, prevention and control of transmission of STDs remain of vital importance and of utmost priority across all regions. Such prevention and control of transmission of syphilis can be possible by early detection diagnostic testing.
In addition, favorable reimbursement policies for STDs testing are expected to drive the syphilis testing market. Increase in prevalence of syphilis, rise in incidences of sex, and technological advancements in syphilis testing kit drive the growth of the syphilis testing market size. In addition, the rise in geriatric population globally boosts the market growth.
The syphilis testing market share is segmented on the basis of type, by location of testing and geography. On the basis of type, the market is segment into primary and secondary syphilis testing. On the basis of location of testing , the market is segmented into laboratory testing & point of care. Geographically, the syphilis testing market forecast is segmented into North America, Europe, Asia-Pacific, and LAMEA.
By Type Segment Review
By Type
The Primary & Secondary Syphilis segment held the largest market share in 2020 and is expected to remain dominant during the forecast period
By type, the syphilis testing market forecast is segmented into primary and secondary syphilis testing. The secondary syphilis segment holds the largest market share whereas the primary syphilis segment is estimated to witness the highest CAGR during the forecast period.
By Location of Testing Segment Review
By location of testing, the syphilis testing market analysis is segmented into laboratory testing & point of care. The laboratory test segment is a highest market contributor in 2020. As laboratory testing is cost efficient, convenient and confidential the laboratory testing segment dominated the market in 2020 and is expected to continue this trend during the forecast period.
By Region Segment Review
By region, the syphilis testing market opportunity is analyzed across North America, Asia-Pacific, Europe, and LAMEA. North America dominated the market in 2020, accounting for the highest share, and is anticipated to maintain this trend during the forecast period.
The major players in the syphilis testing market trends are focusing on technological advancements in developing syphilis testing products along with complementary service portfolios. Some of the key companies profiled in the report are Roche Diagnostics, Hologic, Inc., Becton Dickinson & Company, Abbott Laboratories, BioMerieux, Astam Dignostic, Cepheid Inc., Affymetrix, Inc., and Diasorin.
Key Benefits for Stakeholders
This report provides an extensive analysis of the current and emerging market trends along with the market dynamics of the global syphilis testing industry.
A comprehensive analysis of types and geography segments helps to identify the growth opportunities in the global syphilis testing industry.
Competitive intelligence (of leading manufacturers and distributors of leading syphilis testing devices and services) highlights the business practices followed by leading market players across the geographies.
The projections in the report are made by analyzing the current market trends and market potential for the period of 2020-2030, in terms of value and volume.
SWOT analysis enables to study the internal environment of the leading companies for strategy formulation.
Syphilis Testing Market Report Highlights
| Aspects | Details |
 By Type |
|
 By Location of Testing |
|
 By Region |
|
 Key Market Players | Hologic, Inc., DiaSorin, Becton Dickinson And Company, Bio-Rad Laboratories, F. Hoffmann-La Roche, Abbott Laboratories, Cepheid Inc., siemens healthcare, beckman coulter, Affymetrix, Inc |
Analyst Review
The syphilis testing market is expected to witness a steady growth in the future. The market has drawn the interest of the healthcare industry, owing to increase in prevalence of sexually transmitted disease. The incidence, prevalence and management or the prevention, treatment, and control of further transmission of the syphilis disease prove to be a drag on both, national health budgets and household income. Hence, prevention and control of transmission of syphilis is imperative and of utmost priority across all nations. Such control and prevention of transmission of sexually transmitted diseases is possible by the early diagnostic testing.
The key factors that propel the market growth include, increase in prevalence of sexually transmitted diseases, increase in awareness about the disease, and rise in geriatric population across the globe. In addition, the emergence of novel syphilis testing techniques for treatment with fewer side effects is expected to boost the market growth. Moreover, technological advancement and initiatives taken by government and private organizations to develop the pharmaceutical industry propel the growth of the syphilis testing market. However, side effects of the syphilis treatment, such as fever, headache, muscle pain. And others are expected to restrict the market growth during the forecast period.
Countries such as U.S., Belgium, Germany and France are the leading countries affected by Syphilis.
North America is dominated the market in 2020, accounting for the highest share, and is anticipated to maintain this trend during the forecast period.
The syphilis testing market was valued at $ 1,125.1 million in 2020, and is projected to reach $ $1,935.8 million by 2030, registering a CAGR of 5.6% from 2021 to 2030.
Companies such as Roche Diagnostics, Hologic, Inc., Becton Dickinson & Company, Abbott Laboratories held the major market share in Syphilis Testing
The key factor that drives the syphilis testing market growth new infections that are transmitted by and among MSM (Men who have sex with men) population, injecting drug users, and sex workers.
Loading Table Of Content...
